EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

CD34 ‐Positive Acral Chondromyxoid Mesenchymal Neoplasm Harboring a Novel TCF4::ERG Fusion

Eric C Honaker iD, Laura M Warmke iD, Ameline Baptiste iD, Daniel Baumhoer, Esther Baranov, Eitan Halper-Stromberg, Carina A Dehner iD

Genes, Chromosomes and Cancer · 2025

DOI: 10.1002/gcc.70073 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2025. Verfasst von Eric C Honaker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Antigens, CD34, Oncogene Proteins, Fusion, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Transcription Factors. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular testing has significantly transformed the field of anatomic pathology over the past several decades. Despite these advances, acral mesenchymal neoplasms remain diagnostically challenging, requiring careful integration of clinical presentation, histologic features, and molecular findings for accurate classification. Herein, we present a case of an acral chondromyxoid mesenchymal neoplasm harboring a novel in‐frame TCF4::ERG fusion involving the right index finger of a 26‐year‐old female. Morphologically, this tumor consisted of nests and sheets of monotonous small round‐to‐ovoid cells embedded in a background of chondromyxoid stroma and hyalinized collagen. The tumor cells were diffusely CD34, ERG, and focally p63 reactive, while S100 protein, cytokeratin AE1/AE3, Pan‐TRK, ALK, smooth muscle actin, and desmin were negative. Albeit short follow‐up (3 months), the patient continues to do well without evidence of metastasis or local recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, CD34Oncogene Proteins, FusionBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTranscription FactorsHumansFemaleAdultFingersTranscription Factor 4

Stichwörter der Autor:innen

CD34‐positiveERGTCF4acral chondromyxoid tumormesenchymal tumor

Substanzen

Antigens, CD34Oncogene Proteins, FusionBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTCF4 protein, humanTranscription FactorsTranscription Factor 4

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Bone Tumor Reference Center at the Institute of Medical Genetics and Pathology, University Hospital and University of Basel, Basel, Switzerland.
  • Basel Research Centre for Child Health, Basel, Switzerland.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Eric C Honaker, Laura M Warmke, Ameline Baptiste, Carina A Dehner

Zitieren

APA

Honaker, E. C., Warmke, L. M., Baptiste, A., Baumhoer, D., Baranov, E., Halper-Stromberg, E., & Dehner, C. A. (2025). CD34 ‐Positive Acral Chondromyxoid Mesenchymal Neoplasm Harboring a Novel TCF4::ERG Fusion. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70073

Vancouver

Honaker EC, Warmke LM, Baptiste A, Baumhoer D, Baranov E, Halper-Stromberg E, et al. CD34 ‐Positive Acral Chondromyxoid Mesenchymal Neoplasm Harboring a Novel TCF4::ERG Fusion. Genes, Chromosomes and Cancer. 2025. doi:10.1002/gcc.70073

BibTeX
@article{Honaker2025,
  author = {Honaker, Eric C and Warmke, Laura M and Baptiste, Ameline and Baumhoer, Daniel and Baranov, Esther and Halper-Stromberg, Eitan and Dehner, Carina A},
  title = {CD34 ‐Positive Acral Chondromyxoid Mesenchymal Neoplasm Harboring a Novel TCF4::ERG Fusion},
  journal = {Genes, Chromosomes and Cancer},
  year = {2025},
  doi = {10.1002/gcc.70073}
}
Kostenlos starten →